111 related articles for article (PubMed ID: 4056874)
21. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
Walker MD; Alexander E; Hunt WE; MacCarty CS; Mahaley MS; Mealey J; Norrell HA; Owens G; Ransohoff J; Wilson CB; Gehan EA; Strike TA
J Neurosurg; 1978 Sep; 49(3):333-43. PubMed ID: 355604
[TBL] [Abstract][Full Text] [Related]
22. Neurological deficit after carotid infusion of cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) for malignant glioma: an analysis of risk factors.
Kapp JP; Sanford RA
Neurosurgery; 1986 Nov; 19(5):779-83. PubMed ID: 3785625
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of C6 glioma in vivo by combination chemotherapy of implantation of polymer wafer and intracarotid perfusion of transferrin-decorated nanoparticles.
Han L; Ren Y; Long L; Zhong Y; Shen C; Pu P; Yuan X; Kang C
Oncol Rep; 2012 Jan; 27(1):121-8. PubMed ID: 21922149
[TBL] [Abstract][Full Text] [Related]
24. Pre-irradiation internal carotid artery BCNU in treatment of glioblastoma multiforme.
Bashir R; Hochberg FH; Linggood RM; Hottleman K
J Neurosurg; 1988 Jun; 68(6):917-9. PubMed ID: 2836567
[TBL] [Abstract][Full Text] [Related]
25. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
Safdari H; Mompeon B; Dubois JB; Gros C
Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
[TBL] [Abstract][Full Text] [Related]
26. Analysis and distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in biological specimens.
Hochberg FH; Poletti CE; Krull IS; Strauss J
Neurosurgery; 1983 Sep; 13(3):230-3. PubMed ID: 6621835
[TBL] [Abstract][Full Text] [Related]
27. The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma.
Nagpal S
Neurosurg Clin N Am; 2012 Apr; 23(2):289-95, ix. PubMed ID: 22440872
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.
Tyler JL; Yamamoto YL; Diksic M; Théron J; Villemure JG; Worthington C; Evans AC; Feindel W
J Nucl Med; 1986 Jun; 27(6):775-80. PubMed ID: 3486962
[TBL] [Abstract][Full Text] [Related]
29. Selective delivery of chemotherapeutic agents with a new catheter system.
Wolpert SM; Kwan ES; Heros D; Kasdon DL; Hedges TR
Radiology; 1988 Feb; 166(2):547-9. PubMed ID: 3336733
[TBL] [Abstract][Full Text] [Related]
30. Superselective injection of BCNU through a latex calibrated-leak balloon.
Debrun GM; Davis KR; Hochberg FH
AJNR Am J Neuroradiol; 1983; 4(3):399-400. PubMed ID: 6410755
[TBL] [Abstract][Full Text] [Related]
31. Opening blood-brain-barrier by intracarotid infusion of papaverine in treatment of malignant cerebral glioma.
Xue H; Wang H; Kong L; Zhou H
Chin Med J (Engl); 1998 Aug; 111(8):751-3. PubMed ID: 11245034
[TBL] [Abstract][Full Text] [Related]
32. Fatal necrotizing encephalopathy complicating treatment of malignant gliomas with intra-arterial BCNU and irradiation: a pathological study.
Rosenblum MK; Delattre JY; Walker RW; Shapiro WR
J Neurooncol; 1989 Sep; 7(3):269-81. PubMed ID: 2795121
[TBL] [Abstract][Full Text] [Related]
33. Intra-arterial chemotherapy for brain tumors.
Hassenbusch SJ; Anderson JH; Whiting DM
Cleve Clin J Med; 1990 Sep; 57(6):513-20. PubMed ID: 2268962
[TBL] [Abstract][Full Text] [Related]
34. Phase-I trial of intracarotid BCNU and cisplatin in patients with malignant intracerebral tumors.
Feun LG; Wallace S; Yung WK; Lee YY; Leavens ME; Moser R; Savaraj N; Burgess MA; Plager C; Benjamin RS
Cancer Drug Deliv; 1984; 1(3):239-45. PubMed ID: 6544123
[TBL] [Abstract][Full Text] [Related]
35. Visual system toxicity following intra-arterial chemotherapy.
Kupersmith MJ; Frohman LP; Choi IS; Foo SH; Hiesinger E; Berenstein A; Wise A; Carr RE; Ransohoff J
Neurology; 1988 Feb; 38(2):284-9. PubMed ID: 3340295
[TBL] [Abstract][Full Text] [Related]
36. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
[TBL] [Abstract][Full Text] [Related]
37. Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.
Théron J; Villemure JG; Worthington C; Tyler JL
Neuroradiology; 1986; 28(2):118-25. PubMed ID: 3703233
[TBL] [Abstract][Full Text] [Related]
38. Prevention of ocular toxicity of carmustine (BCNU) with supraophthalmic intracarotid infusion.
Chrousos GA; Oldfield EH; Doppman JL; Cogan DG
Ophthalmology; 1986 Nov; 93(11):1471-5. PubMed ID: 3808609
[TBL] [Abstract][Full Text] [Related]
39. Superselective arterial BCNU infusion in the treatment of patients with malignant gliomas.
Clayman DA; Wolpert SM; Heros DO
AJNR Am J Neuroradiol; 1989; 10(4):767-71. PubMed ID: 2549772
[TBL] [Abstract][Full Text] [Related]
40. Supraophthalmic carotid infusion with low dose cisplatin and BCNU for malignant glioma.
Vance RB; Kapp JP
J Neurooncol; 1986; 3(4):287-90. PubMed ID: 3958775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
